12/02/2024, 12:00 PM UTC
英诺赛科通过上市备案InnoScience passes overseas listing filing
<p>➀ 英诺赛科已通过中国证监会境外上市备案；</p><p>➁ 计划发行不超过1.07亿股境外上市普通股，在香港联合交易所上市；</p><p>➂ 51名股东拟将合计4.44亿股境内未上市股份转为境外上市股份，并在香港联合交易所上市流通；</p><p>➃ 2023年收入约5.93亿元，同比增长769%，净亏损约11.01亿元，同比减少67.58%；</p><p>➄ 截至2023年12月31日，氮化镓产品线完备，累计出货量超过5亿颗；</p><p>➅ 拥有全球最大的氮化镓功率半导体生产基地，月设计产能为1万片；</p><p>➆ 募资计划包括扩大8英寸氮化镓晶圆产能和产品研发。</p><p>➀ InnoScience has passed the overseas listing filing with the China Securities Regulatory Commission;</p><p>➁ Plans to issue up to 107 million ordinary shares for overseas listing on the Hong Kong Stock Exchange;</p><p>➂ 51 shareholders will convert a total of 4.44 billion shares of unlisted shares in the mainland to overseas listed shares;</p><p>➃ Revenue increased by 769% to approximately 5.93 billion yuan in 2023, with a net loss of approximately 1.101 billion yuan, a decrease of 67.58% from 2021;</p><p>➄ Nitride semiconductor product line complete, with cumulative shipments exceeding 500 million units as of December 31, 2023;</p><p>➅ Global largest nitride semiconductor power device production base, with a monthly design capacity of 10,000 wafers;</p><p>➆ Fundraising plan includes expanding 8-inch nitride semiconductor wafer production capacity and product R&D.</p>
---
本文由大语言模型（LLM）生成，旨在为读者提供半导体新闻内容的知识扩展（Beta）。
